Furthermore, our in-silico knockout in breast cancer and paired primary and metastatic site mouse scRNA-seq datasets showed that a loss of SP1 in high metastatic cells could reverse the fates to a low metastatic state. This evidence concerns the gene SP1 and breast cancer.